Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype

scientific article published on 23 November 2011

Rationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/EUROPACE/EUR352
P8608Fatcat IDrelease_ixvidyotgfgd7kqb6ljlgzskaq
P932PMC publication ID3283222
P698PubMed publication ID22117037
P5875ResearchGate publication ID51830319

P50authorRik WillemsQ73762617
Joachim SeegersQ42611605
Rachel C MylesQ57398717
Tim FriedeQ58452336
P2093author name stringMarkus Zabel
Gerd Hasenfuß
Stephan E Lehnart
Jürgen Brockmöller
Marc A Vos
Dimitrios T Kremastinos
Christian Sohns
Vincent Floré
Mathias Meine
Lars Lüthje
Dirk Vollmann
Dirk Simon
Panagiota Flevari
Anton Tuinenburg
EUTrigTreat Clinical Study Investigators
P2860cites workHeart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and ElectrophysiologyQ71338662
Relation between repolarization and refractoriness during programmed electrical stimulation in the human right ventricle. Implications for ventricular tachycardia inductionQ72187978
Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointesQ80273108
Biventricular pacing does not affect microvolt T-wave alternans in heart failure patientsQ80804942
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the AQ82010700
The Ser96Ala variant in histidine-rich calcium-binding protein is associated with life-threatening ventricular arrhythmias in idiopathic dilated cardiomyopathyQ24311983
Prognostic importance of defibrillator shocks in patients with heart failureQ24631203
Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fractionQ28208692
Molecular mechanism for an inherited cardiac arrhythmiaQ33173678
Results and efficiency of programmed ventricular stimulation with four extrastimuli compared with one, two, and three extrastimuliQ33174010
A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmiasQ33175452
Cardiac troponin T mutations promote life-threatening arrhythmiasQ33346362
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failureQ34386004
Interpretation and classification of microvolt T wave alternans testsQ34657147
Sample size recalculation in internal pilot study designs: a reviewQ36593600
Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veteransQ39595577
Sudden cardiac death: epidemiology, transient risk, and intervention assessmentQ40779541
An antidote for calcium leak: targeting molecular arrhythmia mechanismsQ43237259
Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impactQ43848349
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk studyQ44840837
Internal pilots for observational studiesQ44913535
A new single catheter technique for simultaneous measurement of action potential duration and refractory period in vivoQ46175347
T-wave alternans, restitution of human action potential duration, and outcomeQ46187746
The Na+/Ca2+ exchange blocker SEA0400 fails to enhance cytosolic Ca2+ transient and contractility in canine ventricular cardiomyocytesQ46770251
How to avoid inappropriate shocksQ47734230
Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.Q50744359
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of CardioloQ51137889
Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) triaQ51447936
Inappropriate therapy and fatal proarrhythmia by an implantable cardioverter-defibrillator.Q51492028
Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variantsQ57087763
Heart rate variability: Standards of measurement, physiological interpretation, and clinical useQ57309208
Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarctionQ62383735
An Introduction to High-Resolution ECG Recordings of Cardiac Late PotentialsQ68462487
Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trialsQ70908848
P433issue3
P304page(s)416-422
P577publication date2011-11-23
P1433published inEP EuropaceQ2596718
P1476titleRationale, objectives, and design of the EUTrigTreat clinical study: a prospective observational study for arrhythmia risk stratification and assessment of interrelationships among repolarization markers and genotype
P478volume14

Reverse relations

cites work (P2860)
Q41436835Analysis of 24-h Rhythm in Ventricular Repolarization Identifies QT Diurnality As a Novel Clinical Parameter Associated with Previous Ventricular Arrhythmias in Heart Failure Patients
Q36868452Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?
Q35542391Increased Short-Term Beat-To-Beat Variability of QT Interval in Patients with Acromegaly
Q52713851[Current impact of cardiac implantable electronic devices].

Search more.